Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Residual beta-cell function and its metabolic consequences.

C Binder, O K Faber

    Diabetes
    |January 1, 1978
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Recruiting refugees and migrants as potential hematopoietic stem cell donors to serve patients of comparable ethnicities with rare human leucocyte antigen patterns - The BluStar.NRW project in North Western Germany.

    Transplant immunology·2024
    Same author

    Expression of nuclear progesterone receptor, progesterone receptor membrane components 1 and 2 and prostaglandin-endoperoxide synthase 2 in the endometrium and oviduct of spontaneously ovulating cats.

    Theriogenology·2021
    Same author

    Using egg yolk in a TRIS-Equex STM paste extender for freezing of dog semen is superior to egg yolk plasma, also after addition of lecithin and catalase.

    Cryobiology·2021
    Same author

    [Atypical retinal vasculitis].

    Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·2017
    Same author

    Beneficial effects of levosimendan on survival in patients undergoing extracorporeal membrane oxygenation after cardiovascular surgery.

    British journal of anaesthesia·2016
    Same author

    Comparison of bacterial counts in expressed breast milk following standard or strict infection control regimens in neonatal intensive care units: compliance of mothers does matter.

    The Journal of hospital infection·2016
    Same journal

    Ketone Bodies Derived From Medium-Chain Triglycerides Support Brain Metabolism and Function Under Hypoglycemia in Type 1 Diabetes Mellitus.

    Diabetes·2026
    Same journal

    Targeting the ADA/ADO Axis Rescues β-Cell Failure in Type 2 Diabetes.

    Diabetes·2026
    Same journal

    TXNIP Is Positioned as a Key Mediator of Hyperglycemia-Induced Vascular Senescence.

    Diabetes·2026
    Same journal

    Sex Differences in ER Stress Pathways Are a Key Determinant of β-Cell Proliferation and Resilience.

    Diabetes·2026
    Same journal

    The Mechanism of TNF-α Combined With High Glucose in Regulating Calnexin Aggravates Endoplasmic Reticulum Stress in Endothelial Cell Injury of Diabetic Retinopathy.

    Diabetes·2026
    Same journal

    β-Hydroxybutyrate Improves Glucose Metabolism in Streptozotocin-Induced Type 1 Diabetes by Inhibiting Gut and Liver Glucose Transporters via GPR109A.

    Diabetes·2026
    See all related articles

    Residual beta-cell function is common in insulin-treated diabetes patients for years after diagnosis. This function aids in achieving good glycemic control, with higher C-peptide levels indicating better stability.

    Area of Science:

    • Endocrinology
    • Metabolic Diseases
    • Diabetes Mellitus Research

    Background:

    • Advancements in C-peptide immunoassay sensitivity and specificity enhance understanding of residual beta-cell function.
    • Residual beta-cell function impacts metabolic outcomes in patients with insulin-treated diabetes mellitus.

    Purpose of the Study:

    • To explore the prevalence and significance of residual beta-cell function in insulin-treated diabetic patients.
    • To investigate the relationship between residual beta-cell function, glycemic control, and patient stability.

    Main Methods:

    • Utilized improved C-peptide immunoassays for sensitive detection.
    • Analyzed data from larger patient cohorts to assess residual beta-cell function.

    Main Results:

    Related Experiment Videos

    • Residual beta-cell function is present in most insulin-treated patients within the first 5-10 years post-diagnosis.
    • This function is largely independent of initial symptom severity and only partially related to age at diagnosis.
    • Higher plasma C-peptide concentrations correlate with patient stability, though unmeasurable C-peptide doesn't always mean poor control.

    Conclusions:

    • Residual beta-cell function plays a crucial role in facilitating good glycemic control in insulin-treated diabetes.
    • Further research is required to fully understand the implications of even minimal beta-cell reserve.
    • The qualitative and quantitative aspects of beta-cell function decline in diabetes warrant further investigation.